Aoxing Pharma Revenue, Profits - AOXG Annual Income Statement

Add to My Stocks
$0.03 $0 (0%) AOXG stock closing price Oct 12, 2018 (Closing)

Fundamental analysis of AOXG stock involves analyzing its financial statements, apart from checking the Aoxing Pharma stock price. The key financial statements of a company are the income statement, the balance sheet and the cash flow statement. The income statement for AOXG which shows a YOY revenue growth of 26.84% is specific to a period of time. Investors typically check YoY or QoQ revenue growth. One also needs to look at Aoxing Pharma assets, operating expenses and Aoxing Pharma free cash flow. The Aoxing Pharma profit and loss statement shows revenue of $32.32M for 2016. Revenue has grown by 26.84% YOY for AOXG stock.

View revenue and profit details for latest and last 10 financial years.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jul - Jun20162015201420132012201120102009
Aoxing Pharma Revenues or Net Sales
32.32M25.48M12.73M10.82M8.13M6.65M6.11M8.94M
Cost Of Goods Sold (COGS)7.77M5.68M6.92M4.56M3.23M3.32M2.34M5.13M
Aoxing Pharma Gross Profit
24.55M19.79M5.81M6.26M4.89M3.32M3.77M3.8M
Research & Development Expense3.14M--1.48M--1.54M-
Selling General & Admin Expense14.67M10.21M7.96M11.36M4.87M6.39M5.17M6.74M
Income Before Depreciation Depletion Amortization6.73M9.24M-2.72M-6.58M-0.55M-3.99M-2.93M-3.66M
Depreciation Depletion Amortization---7.64M13.99M---
Non Operating Income---0.1M-0.08M-1.91M5.1M-0.05M
Interest Expense3.45M5.76M5.19M2.98M1.86M1.74M2.42M1.91M
Aoxing Pharma Pretax Income
2.88M3.11M-8.63M-17.29M-15.87M-4.42M-0.9M-5.97M
Provision for Income Taxes--2.7M-----0.06M-3.28M
MinorityInterest---0.41M-0.48M-0.05M-0.27M-0.01M-
Investment Gains Losses--------
Other Income--------
Income Before Extraordinaries & Disc Operations2.24M5.81M-8.63M-17.29M-15.87M-5.2M-0.84M-2.69M
Extraordinary Items & Discontinued Operations--------
Aoxing Pharma Profit/ Loss (Net Income)
2.06M5.49M-8.21M-16.8M-15.82M-4.92M-0.83M-2.69M
Average Shares used to compute Diluted EPS75.47M63.11M49.86M49.75M49.35M46.58M45.58M41.2M
Average Shares used to compute Basic EPS73.7M63.11M49.86M49.75M49.35M46.58M45.58M41.2M
Income Before Nonrecurring Items2.06M5.5M-8.22M-9.75M-2.42M-6.17M-3.24M-2.11M
Income from Nonrecurring Items----7.06M-13.4M1.24M2.41M-0.58M
Aoxing Pharma Earnings Per Share Basic Net
0.030.09-0.16-0.34-0.32-0.11-0.02-0.06
Aoxing Pharma Earnings Per Share Diluted Net
0.030.09-0.16-0.34-0.32-0.11-0.02-0.06
EPS Diluted Before Nonrecurring Items0.030.09-0.16-0.20-0.05-0.13-0.07-0.06
Preferred Dividends Acc Pd--------
Dividends Common--------
Dividend Per Share Common0.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

It is very helpful to read a report on Aoxing Pharma stock analysis. An investor must check the following items in an income statement:

  • Revenue: The money received by selling of goods or services comes under this line item. A YoY growth - See: Aoxing Pharma revenue chart implies that the company is growing. It has been the case with Aoxing Pharma. One must look at stocks with increasing revenues, and stay away from stocks whose revenues or sales are declining.
  • Bottom line: This refers to the last line in a profit and loss statement and denotes the net profit or loss for a particular period. The figure currently stands at $2.06M for Aoxing Pharma for 2016. This figure is arrived at after deducting all operating expenses, interest, and taxes from revenue.

The income statement is also called the profit and loss statement. Apart from the AOXG income statement, one can check the Aoxing Pharma historical stock prices to check how the price has moved with time.

Aoxing Pharma Income Statement - Key Financial Ratios